Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients

Todd Neale

September 12, 2025

News Daily News

ASNC Fighting Back Against Proposed Reimbursement Cuts for Amyloid Imaging

Yael L. Maxwell

September 11, 2025

News Daily News

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

Caitlin E. Cox

June 09, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Caitlin E. Cox

March 21, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality

Yael L. Maxwell

December 12, 2024

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

News Daily News

Carpal Tunnel Syndrome Again Tied to Heart Failure: German Data

Caitlin E. Cox

July 19, 2023

News Daily News

ATTRibute-CM Top-Line Results Favorable for Acoramidis

L.A. McKeown

July 17, 2023

News Daily News

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

Todd Neale

October 20, 2021

News Daily News

Carpal Tunnel Linked to Higher Rates of Amyloidosis and Heart Failure

L.A. McKeown

July 02, 2019

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

Advertisement

Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients

ASNC Fighting Back Against Proposed Reimbursement Cuts for Amyloid Imaging

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Top Heart Failure News of 2024

Before a Cardiomyopathy Diagnosis, TTR Destabilization Portends Higher Mortality

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Carpal Tunnel Syndrome Again Tied to Heart Failure: German Data

ATTRibute-CM Top-Line Results Favorable for Acoramidis

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

Carpal Tunnel Linked to Higher Rates of Amyloidosis and Heart Failure

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content